Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Premium Company Profile - Endo Pharmaceuticals (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 27/11/2007
- Report Title: Premium Company Profile - Endo Pharmaceuticals
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 58
Introduction
Endo Pharmaceuticals' main focus is to develop and market prescription drugs for pain management. The company's marketed product, Lidoderm, indicated for the relief of pain associated with post-herpetic neuralgia, has been the major contributor to its revenues. Further, the company's acquisition of RxKinetix in 2006 provided an expansion of the company into therapeutic areas.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals. The company has a portfolio of branded products that includes: Lidoderm, Percocet, Frova, Percodan, Opana, Opana ER and Synera.
The company's lead product candidate EN 3285 Oral Rinse for treating Oral mucositis is currently in Phase 2 clinical trials. In addition, Endo Pharmaceuticals has two licensed products in Phase 3 namely: topical ketoprofen patch and rapinyl used for treating pain associated with soft tissue injuries and cancer, respectively.
Endo Pharmaceuticals derives its revenues from product sales of its proprietary and in-licensed products. The company's total revenues increased at a CAGR of 10.9% during 2002-2006, from $399 million to $909.7 million. This represents an absolute total growth of +$510 million for total revenues.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
